These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 25449428)
1. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model. Ahn E; Kim H; Han KT; Sin JI Cancer Lett; 2015 Jan; 356(2 Pt B):676-85. PubMed ID: 25449428 [TBL] [Abstract][Full Text] [Related]
2. MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model. Lee SY; Sin JI Hum Vaccin Immunother; 2015; 11(8):2012-20. PubMed ID: 25902414 [TBL] [Abstract][Full Text] [Related]
3. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
4. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity. Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590 [TBL] [Abstract][Full Text] [Related]
5. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice. Song K; Chang Y; Prud'homme GJ Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590 [TBL] [Abstract][Full Text] [Related]
6. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal. Lee H; Park HJ; Sohn HJ; Kim JM; Kim SJ J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474 [TBL] [Abstract][Full Text] [Related]
8. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [TBL] [Abstract][Full Text] [Related]
9. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348 [TBL] [Abstract][Full Text] [Related]
10. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice. Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311 [TBL] [Abstract][Full Text] [Related]
11. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer. Song K; Chang Y; Prud'homme GJ Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021 [TBL] [Abstract][Full Text] [Related]
12. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Dai S; Wan T; Wang B; Zhou X; Xiu F; Chen T; Wu Y; Cao X Clin Cancer Res; 2005 Oct; 11(20):7554-63. PubMed ID: 16243831 [TBL] [Abstract][Full Text] [Related]
13. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination. Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201 [TBL] [Abstract][Full Text] [Related]
14. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. Xiang R; Primus FJ; Ruehlmann JM; Niethammer AG; Silletti S; Lode HN; Dolman CS; Gillies SD; Reisfeld RA J Immunol; 2001 Oct; 167(8):4560-5. PubMed ID: 11591784 [TBL] [Abstract][Full Text] [Related]
15. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses. Kudo-Saito C; Schlom J; Hodge JW Clin Cancer Res; 2005 Mar; 11(6):2416-26. PubMed ID: 15788693 [TBL] [Abstract][Full Text] [Related]
16. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity. Aarts WM; Schlom J; Hodge JW Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537 [TBL] [Abstract][Full Text] [Related]
17. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339 [TBL] [Abstract][Full Text] [Related]
18. Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells. Park MY; Kim HS; Woo SJ; Kim CH; Park JS; Sohn HJ; Kim HJ; Oh ST; Kim TG Eur J Immunol; 2008 Aug; 38(8):2106-17. PubMed ID: 18624349 [TBL] [Abstract][Full Text] [Related]
19. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556 [TBL] [Abstract][Full Text] [Related]
20. Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses. Kim H; Kwon B; Sin JI PLoS One; 2013; 8(12):e83765. PubMed ID: 24391824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]